Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms.
With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management.
By:
Philipp N. Baecker Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Country of Publication: Germany Edition: 2007 ed. Volume: 587 Dimensions:
Height: 235mm,
Width: 155mm,
Spine: 15mm
Weight: 910g ISBN:9783540482635 ISBN 10: 3540482636 Series:Lecture Notes in Economics and Mathematical Systems Pages: 282 Publication Date:10 January 2007 Audience:
Professional and scholarly
,
Undergraduate
Format:Paperback Publisher's Status: Active